AVI BioPharma receives U.S. patent on stem cell technology

01/20/2005 | Times Leader (Wilkes-Barre, Pa.)

Shares in AVI BioPharma more than doubled Wednesday on the announcement it had received one patent and a notice of allowance on another, both dealing with certain agents that modulate stem cell maturation. One analyst said the news the company was moving into the stem cell area contributed to its share price rise because stem cells are "hot right now," but said he expected enthusiasm over the development to decline because it is too early to know if the technology will yield anything.

View Full Article in:

Times Leader (Wilkes-Barre, Pa.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA